BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16978940)

  • 1. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
    Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
    Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for ductal carcinoma in situ: a decision analysis.
    Punglia RS; Burstein HJ; Weeks JC
    Cancer; 2012 Feb; 118(3):603-11. PubMed ID: 21720992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns.
    Mokbel K; Alamoodi M
    Breast Cancer Res Treat; 2024 Jun; 205(2):423-424. PubMed ID: 38361145
    [No Abstract]   [Full Text] [Related]  

  • 4. Two Cases of Distant Metastasis After Mastectomy for Breast Ductal Carcinoma In Situ.
    Hamaoka T; Bando H; Okazaki M; Iguchi-Manaka A; Hara H
    Cureus; 2024 May; 16(5):e59655. PubMed ID: 38836147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
    Kelley L; Silverstein M; Guerra L
    Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.
    Kada Mohammed S; Dabakuyo Yonli TS; Desmoulins I; Manguem Kamga A; Jankowski C; Padeano MM; Loustalot C; Costaz H; Causeret S; Peignaux K; Rouffiac M; Coutant C; Arnould L; Ladoire S
    Breast Cancer Res Treat; 2023 Jan; 197(2):377-385. PubMed ID: 36417042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.
    Hrebinko KA; Bryce CL; Downs-Canner S; Diego EJ; Myers SP
    Cancer; 2022 Jun; 128(12):2258-2268. PubMed ID: 35389517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.
    Lee SE; Kim HY; Yoon JH; Kim EK; Kim JY; Kim MJ; Kim GR; Park YV; Moon HJ
    Ann Surg Oncol; 2021 Dec; 28(13):8699-8709. PubMed ID: 34196861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.
    Park HL; Chang J; Lal G; Lal K; Ziogas A; Anton-Culver H
    Clin Breast Cancer; 2018 Apr; 18(2):e179-e185. PubMed ID: 28941977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer.
    Yoshida T; Jin K; Song H; Park S; Huso DL; Zhang Z; Liangfeng H; Zhu C; Bruchertseifer F; Morgenstern A; Sgouros G; Sukumar S
    Oncotarget; 2016 May; 7(22):33306-15. PubMed ID: 27119227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
    J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base.
    Flanagan MR; Rendi MH; Gadi VK; Calhoun KE; Gow KW; Javid SH
    Ann Surg Oncol; 2015 Oct; 22(10):3264-72. PubMed ID: 26202556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis.
    Klein J; Kong I; Paszat L; Nofech-Mozes S; Hanna W; Thiruchelvam D; Narod SA; Saskin R; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Jani PA; Slodkowska E; Bonin M; Rakovitch E
    Springerplus; 2015; 4():335. PubMed ID: 26185737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
    Borgquist S; Zhou W; Jirström K; Amini RM; Sollie T; Sørlie T; Blomqvist C; Butt S; Wärnberg F
    BMC Cancer; 2015 Jun; 15():468. PubMed ID: 26062614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
    Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG
    Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients.
    Shah C; Vicini FA; Berry S; Julian TB; Wilkinson JB; Shaitelman SF; Khan A; Finkelstein SE; Goldstein N
    Am J Clin Oncol; 2015 Oct; 38(5):526-33. PubMed ID: 25036472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer.
    Narod SA; Rakovitch E
    Curr Oncol; 2014 Jun; 21(3):119-24. PubMed ID: 24940092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.
    Kong I; Narod SA; Taylor C; Paszat L; Saskin R; Nofech-Moses S; Thiruchelvam D; Hanna W; Pignol JP; Sengupta S; Elavathil L; Jani PA; Done SJ; Metcalfe S; Rakovitch E
    Curr Oncol; 2014 Feb; 21(1):e96-e104. PubMed ID: 24523627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.
    Zhou W; Johansson C; Jirström K; Ringberg A; Blomqvist C; Amini RM; Fjallskog ML; Wärnberg F
    Int J Breast Cancer; 2013; 2013():582134. PubMed ID: 24490077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
    Fitzsullivan E; Lari SA; Smith B; Caudle AS; Krishnamurthy S; Lucci A; Mittendorf EA; Babiera GV; Black DM; Wagner JL; Bedrosian I; Woodward W; Gainer SM; Hwang R; Meric-Bernstam F; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2013 Dec; 20(13):4103-12. PubMed ID: 23975313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.